Status:
COMPLETED
Functional Roll for Non-alcoholic Fatty Liver Disease
Lead Sponsor:
Pomeranian Medical University Szczecin
Collaborating Sponsors:
Humboldt-Universität zu Berlin
Conditions:
Non-Alcoholic Fatty Liver Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background: Low physical activity and poor eating habits (incl. high fat and carbohydrates but low fiber intake) are the main reason of obesity epidemic in western societies. The most common clinical ...
Detailed Description
Background: High percentage of the Polish suffer from overweight and obesity. According to previous report prepared for the government, the percentage of overweight and obese people in Poland was 36.6...
Eligibility Criteria
Inclusion
- NAFLD diagnosis based on non-invasive assessment
Exclusion
- other liver disease: ALD, viral hepatitis, AIH, cholestatic liver disease, Wilson's disease, hemochromatosis, hepatobiliary cancer (HCC, CCA), incl. liver cirrhosis of any aetiology
- alcohol consumption \> 21 standard drinks per week in men or \>14 standard drinks per week in women over at least a two-year period,
- diabetes
- pregnancy
- celiac disease
- inflammation bowel disease
- starvation, parenteral nutrition
- drugs: metformin and other antidiabetics, statins, amiodarone, methotrexate, tamoxifen, glucocorticoids, valproate, anti-retroviral agents for HIV
Key Trial Info
Start Date :
November 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2019
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT04520724
Start Date
November 1 2018
End Date
November 1 2019
Last Update
August 20 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pomeranian Medical University
Szczecin, West Pomeranian Voivodeship, Poland, 70-393